Jobs für corruption bei Basel

8 corruption Stellenangebote in Schweiz. Täglich aktualisierte Angebote.


  • Basel, Basel-Stadt, Schweiz Revolution Medicines Vollzeit

    ppRevolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s RD pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

  • Senior Specialist, IT

    Vor 4 Tagen


    Basel, Kanton Basel-Stadt, Schweiz Basel Institute on Governance Vollzeit

    Senior Specialist, ITSenior Specialist, ITPlace of work: Basel, SwitzerlandEmployment rate: 50–100%Start date: 1 January 2027 or soonerContract type: PermanentOther: Must be eligible to work in SwitzerlandBasel Institute on GovernanceThe Basel Institute on Governance is a hands-on centre of competence dedicated to promoting good governance and countering...

  • Senior Specialist, IT

    Vor 2 Wochen


    Basel, Basel, BS, Schweiz ETH get hired Vollzeit

    Beschreibung Facebook Twitter LinkedIn of 3 100% Basel Institute on Governance Steinenring 60 | 4051 Basel, Switzerland | +41 61 205 55 11 info@baselgovernance.org | www.baselgovernance.org Senior Specialist, IT Place of work: Basel, Switzerland Employment rate: 50–100% Start date: 1 January...

  • Senior Specialist, IT

    Vor 2 Wochen


    Basel, BS, BS, Schweiz Universität Basel Remote Vollzeit

    Place of work: Basel, Switzerland Employment rate: 50–100% Start date: 1 January 2027 or sooner Contract type: Permanent Other: Must be eligible to work in Switzerland **Basel Institute on Governance** The Basel Institute on Governance is a hands-on centre of competence dedicated to promoting good governance and countering corruption for...


  • Basel, Basel, BS, Schweiz Revolution Medicines Vollzeit

    Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...